Pharmasset announced at Novemver 11, 2005 that five abstracts

related to the development of Clevudine for the treatment of

Hepatitis B will be presented at the 56th Annual Meeting of the

American Association for the Study of Liver Diseases (AASLD)

being held in San Francisco, California from November 11-15,

2005. The Clevudine abstracts can be viewed on the AASLD

website at http://www.aasld.org.





Clevudine-CLV302-AASLD2005.pdf


Clevudine-CLV301-AASLD2005.pdf